Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Dec 2;18(Suppl 6):20258.
doi: 10.7448/IAS.18.7.20258. eCollection 2015.

The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children

Rachel C Vreeman  1   2   3 , Michael L Scanlon  1   2 , Megan S McHenry  1   2 , Winstone M Nyandiko  2   4
Affiliations

The physical and psychological effects of HIV infection and its treatment on perinatally HIV-infected children

Rachel C Vreeman et al. J Int AIDS Soc. .

Abstract

Introduction: As highly active antiretroviral therapy (HAART) transforms human immunodeficiency virus (HIV) into a manageable chronic disease, new challenges are emerging in treating children born with HIV, including a number of risks to their physical and psychological health due to HIV infection and its lifelong treatment.

Methods: We conducted a literature review to evaluate the evidence on the physical and psychological effects of perinatal HIV (PHIV+) infection and its treatment in the era of HAART, including major chronic comorbidities.

Results and discussion: Perinatally infected children face concerning levels of treatment failure and drug resistance, which may hamper their long-term treatment and result in more significant comorbidities. Physical complications from PHIV+ infection and treatment potentially affect all major organ systems. Although treatment with antiretroviral (ARV) therapy has reduced incidence of severe neurocognitive diseases like HIV encephalopathy, perinatally infected children may experience less severe neurocognitive complications related to HIV disease and ARV neurotoxicity. Major metabolic complications include dyslipidaemia and insulin resistance, complications that are associated with both HIV infection and several ARV agents and may significantly affect cardiovascular disease risk with age. Bone abnormalities, particularly amongst children treated with tenofovir, are a concern for perinatally infected children who may be at higher risk for bone fractures and osteoporosis. In many studies, rates of anaemia are significantly higher for HIV-infected children. Renal failure is a significant complication and cause of death amongst perinatally infected children, while new data on sexual and reproductive health suggest that sexually transmitted infections and birth complications may be additional concerns for perinatally infected children in adolescence. Finally, perinatally infected children may face psychological challenges, including higher rates of mental health and behavioural disorders. Existing studies have significant methodological limitations, including small sample sizes, inappropriate control groups and heterogeneous definitions, to name a few.

Conclusions: Success in treating perinatally HIV-infected children and better understanding of the physical and psychological implications of lifelong HIV infection require that we address a new set of challenges for children. A better understanding of these challenges will guide care providers, researchers and policymakers towards more effective HIV care management for perinatally infected children and their transition to adulthood.

Keywords: HIV comorbidities; adolescents; children; development; perinatal HIV infection; psychological complications.

PubMed Disclaimer

References

    1. World Health Organization. Global update on the health sector response to HIV, 2014. Geneva: WHO; 2014.
    1. Lee GM, Gortmaker SL, McIntosh K, Hughes MD, Oleske JM, Pediatric AIDS Clinical Trials Group Protocol 219C Team Quality of life for children and adolescents: impact of HIV infection and antiretroviral treatment. Pediatrics. 2006;117(2):273–83. - PubMed
    1. Delaney M. History of HAART – the true story of how effective multi-drug therapy was developed for treatment of HIV disease. Retrovirology. 2006;3(Suppl 1):S6.
    1. McConnell MS, Byers RH, Frederick T, Peters VB, Dominguez KL, Sukalac T, et al. Trends in antiretroviral therapy use and survival rates for a large cohort of HIV-infected children and adolescents in the United States, 1989–2001. J Acquir Immune Defic Syndr. 2005;38(4):488–94. - PubMed
    1. Mofenson LM, Williams P, Brady MT, van Dyke RB, Dankner WM, Oleske JM. Trends in mortality in HIV-infected children in the United States – 1994–2006. XVII International AIDS Conference Mexico City; 2008 Aug 3–8; Mexico. 2008.